Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Ihsan Nijem"'
Autor:
Judy C. Young, Mark Merchant, Ihsan Nijem, Thomas Gelzleichter, Surinder Kaur, William Mallet, Mally Romero, Ellen Filvaroff, Christophe Severin, Jing Peng, Youjun Chen, Zhong Zheng, Elaine Mai
PDF file - 76K, Supplemental Table 1: Oligonucleotide sequences.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::602f35b92f38a4e317349755783d4b4e
https://doi.org/10.1158/1535-7163.22499713
https://doi.org/10.1158/1535-7163.22499713
Autor:
Judy C. Young, Mark Merchant, Ihsan Nijem, Thomas Gelzleichter, Surinder Kaur, William Mallet, Mally Romero, Ellen Filvaroff, Christophe Severin, Jing Peng, Youjun Chen, Zhong Zheng, Elaine Mai
PDF file - 21K, Supplemental Figure 1. Human sMET (A) and HGF (B) levels in human plasma samples from a panel of 20 renal cell carcinoma patients and 15 normal donors were measured using the MET ECLA (A) and HGF ELISA (B), respectively.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::698324299a1e8945ea2d58c1c0bc79a7
https://doi.org/10.1158/1535-7163.22499716.v1
https://doi.org/10.1158/1535-7163.22499716.v1
Autor:
Judy C. Young, Mark Merchant, Ihsan Nijem, Thomas Gelzleichter, Surinder Kaur, William Mallet, Mally Romero, Ellen Filvaroff, Christophe Severin, Jing Peng, Youjun Chen, Zhong Zheng, Elaine Mai
Onartuzumab, a humanized, monovalent monoclonal anti-MET antibody, antagonizes MET signaling by inhibiting binding of its ligand, hepatocyte growth factor (HGF). We investigated the effects of onartuzumab on cell-associated and circulating (shed) MET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f35c13437b18b0d84db54fef4380a6d
https://doi.org/10.1158/1535-7163.c.6536236
https://doi.org/10.1158/1535-7163.c.6536236
Autor:
Lisa A. Damico-Beyer, Amy Peterson, Judy Young, Elaine Mai, Ihsan Nijem, Teresa Davancaze, Mally Romero, Nelson L. ‘Shasha’ Jumbe, Mark Merchant, Arthur E. Reyes, Brendan C. Bender, Hong Xiang
PDF file, 54K, Estimation of percentage of patients to achieve TSC (15 ug/mL) at Ctrough ss with Q3W dose regimen.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::337175ca57c0a3e19262f2de40af570d
https://doi.org/10.1158/1078-0432.22450757
https://doi.org/10.1158/1078-0432.22450757
Autor:
Lisa A. Damico-Beyer, Amy Peterson, Judy Young, Elaine Mai, Ihsan Nijem, Teresa Davancaze, Mally Romero, Nelson L. ‘Shasha’ Jumbe, Mark Merchant, Arthur E. Reyes, Brendan C. Bender, Hong Xiang
PDF file, 3179K, Representative for visual predictive check.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49848bd2dafa66cd28e892ace574eb94
https://doi.org/10.1158/1078-0432.22450769
https://doi.org/10.1158/1078-0432.22450769
Autor:
Lisa A. Damico-Beyer, Amy Peterson, Judy Young, Elaine Mai, Ihsan Nijem, Teresa Davancaze, Mally Romero, Nelson L. ‘Shasha’ Jumbe, Mark Merchant, Arthur E. Reyes, Brendan C. Bender, Hong Xiang
PDF file, 93K.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed6f07a6a898ae8b71b9cb339bc3941
https://doi.org/10.1158/1078-0432.22450760.v1
https://doi.org/10.1158/1078-0432.22450760.v1
Autor:
Lisa A. Damico-Beyer, Amy Peterson, Judy Young, Elaine Mai, Ihsan Nijem, Teresa Davancaze, Mally Romero, Nelson L. ‘Shasha’ Jumbe, Mark Merchant, Arthur E. Reyes, Brendan C. Bender, Hong Xiang
PDF file, 1199K, Tumor growth inhibition.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3c992710afa9963309c819b3e0dac23
https://doi.org/10.1158/1078-0432.22450778.v1
https://doi.org/10.1158/1078-0432.22450778.v1
Autor:
Rebecca A. Moss, Janice M. Mehnert, Blase Polite, Mark J. Ratain, Amy Peterson, Daniel V.T. Catenacci, Ihsan Nijem, Surinder Kaur, Shuang Bai, Priti Hegde, Steve Eppler, Wei Yu, John Bothos, Premal Patel, Ravi Salgia
PDF file - 88K, Table S1. Treatment-related adverse events across all dosing cohorts in Phase Ia escalation and expansion, and Phase Ib. Table S2. Most commonly reported adverse events regardless of relationship to study drug.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19f7f6584b5adf11cb2797c9f5c4ef90
https://doi.org/10.1158/1078-0432.22451313
https://doi.org/10.1158/1078-0432.22451313
Autor:
Lisa A. Damico-Beyer, Amy Peterson, Judy Young, Elaine Mai, Ihsan Nijem, Teresa Davancaze, Mally Romero, Nelson L. ‘Shasha’ Jumbe, Mark Merchant, Arthur E. Reyes, Brendan C. Bender, Hong Xiang
PDF file, 2424K, Observed individual concentration-time profile of onartuzumab in human in comparison with cyno-based prediction.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d8e184c913834df27081b1558886422
https://doi.org/10.1158/1078-0432.22450763
https://doi.org/10.1158/1078-0432.22450763
Autor:
Lisa A. Damico-Beyer, Amy Peterson, Judy Young, Elaine Mai, Ihsan Nijem, Teresa Davancaze, Mally Romero, Nelson L. ‘Shasha’ Jumbe, Mark Merchant, Arthur E. Reyes, Brendan C. Bender, Hong Xiang
PDF file, 1651K, Representative individual fits.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e770887e481ff05da442fd0713bf86a
https://doi.org/10.1158/1078-0432.22450772.v1
https://doi.org/10.1158/1078-0432.22450772.v1